Jonathan Jesus Molina

Jonathan Jesus Molina

Auto-generated profile, based on publicly available information

Jonathan Jesus Molina

Integrated Biomedical Sciences and Department of Biological Sciences, University of Notre Dame, IN

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2023 in Science Advances
Verified
Journal Article
Closed access
ABAlyssa Ann La Bella
Alyssa Ann La Bella
MAMarissa Andersen
Marissa Andersen
NGNicholas C. Gervais
Nicholas C. Gervais
JMJonathan Jesus Molina
Jonathan Jesus Molina
AMAlex Molesan
Alex Molesan
AFAna Lidia Flores-Mireles
Ana Lidia Flores-Mireles
Catheter-associated urinary tract infections (CAUTIs) account for 40% of hospital-acquired infections (HAIs). As 20 to 50% of hospitalized patients receive catheters, CAUTIs are one of the most common HAIs, resulting in increased morbidity, mortality, and health care costs. Candida albicans is the second most common CAUTI uropathogen, yet relative to its bacterial counterparts, little is known about how fungal CAUTIs are established. Here, we show that the catheterized bladder environment induces Efg1- and fibrinogen (Fg)–dependent biofilm formation that results in CAUTI. In addition, we identify the adhesin Als1 as the critical fungal factor for C. albicans Fg-urine biofilm formation. Furthermore, we show that in the catheterized bladder, a dynamic and open system, both filamentation and attachment are required, but each by themselves are not sufficient for infection. Our study unveils the mechanisms required for fungal CAUTI establishment, which may aid in the development of future therapies to prevent these infections.

1 September 2025 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
JMJonathan J. Molina
Jonathan J. Molina
AFAna Lidia Flores-Mireles
Ana Lidia Flores-Mireles
Hemostasis, a critical physiological process, is essential for stopping bleeding and initiating tissue repair after injury. It involves a tightly coordinated interplay between coagulation (blood clotting) and fibrinolysis (clot breakdown). Dysregulation of hemostasis can result in a wide range of diseases, such as infections, cancers, metabolic disorders, and neurodegenerative disorders. In the urinary tract, disruption of homeostasis and induction of hemostasis by diseases or foreign bodies (such as urinary catheters) can lead to various problems, such as infections, inflammation, and structural damage. Furthermore, hemostatic proteins have been associated with severe cancer progression. Thus, highlighting the roles of clot formation and plasminogen activation in urinary tract pathologies is important. This review details the pathogenesis of the urinary tract and urothelial carcinoma, as well as the roles of clot formation and plasminogen activation during disease onset and progression.